{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:29:03Z","timestamp":1778124543728,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006470","name":"Aristotle University of Thessaloniki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006470","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute pyelonephritis (APN) in pediatric patients may lead to kidney scarring and is one of the main causes of permanent kidney damage. The incidence of kidney scarring after one febrile urinary tract infection (UTI) is reported to range from 2.8 to 15%, with the percentage rising to 28.6% after\u2009\u2265\u20093 febrile UTIs. Corticosteroids may have a role in the reduction of kidney scar formation and urine cytokine levels. The possible benefit of adjuvant corticosteroid administration in the reduction of kidney scar formation in children with APN has been recently examined in randomized controlled trials (RCTs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of this meta-analysis was to provide a summary of the current literature about the efficacy and safety of adjuvant corticosteroid administration in the reduction of kidney scar formation in children with APN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Data sources<\/jats:title>\n                <jats:p>An extensive literature search through major databases (PubMed\/MEDLINE and Scopus) was carried out for RCTs from inception until October 12, 2022, investigating the efficacy and safety of adjuvant corticosteroids in preventing kidney scarring in children with APN. A risk ratio with 95% CI was used for dichotomous outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 5 RCTs with 918 pediatric patients with APN were included in the study. Adjuvant corticosteroid treatment revealed a statistically significant reduction in kidney scarring (95% CI 0.42\u20130.95, <jats:italic>p<\/jats:italic>\u2009=\u20090.03), without increasing the risk of adverse events like bacteremia, prolonged hospitalization, or recurrence of UTI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Limitations<\/jats:title>\n                <jats:p>There were limitations regarding sample size (<jats:italic>n<\/jats:italic>\u2009=\u2009498 children), different classes of corticosteroids (methylprednisolone or dexamethasone), different routes of corticosteroid administration (intravenous or oral), and different day courses (3-day or 4-day course).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Adjuvant corticosteroid administration seems to have a beneficial effect on kidney scar reduction in children with APN. Future studies should focus on the evaluation of the efficacy and safety of corticosteroids in kidney scarring reduction after APN to strengthen the results of our study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00467-023-05922-0","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T10:04:43Z","timestamp":1679393083000},"page":"3937-3945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The efficacy and safety of corticosteroids in pediatric kidney scar prevention after urinary tract infection: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-8520","authenticated-orcid":false,"given":"Nikolaos","family":"Gkiourtzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agni","family":"Glava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moutafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theopisti","family":"Vasileiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Delaporta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Michou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1618-9285","authenticated-orcid":false,"given":"Nikoleta","family":"Printza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2718-7480","authenticated-orcid":false,"given":"Kali","family":"Makedou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0085-7384","authenticated-orcid":false,"given":"Despoina","family":"Tramma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1542\/peds.2010-0685","volume":"126","author":"N Shaikh","year":"2010","unstructured":"Shaikh N, Ewing AL, Bhatnagar S, Hoberman A (2010) Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 126:1084\u20131091. https:\/\/doi.org\/10.1542\/peds.2010-0685","journal-title":"Pediatrics"},{"key":"5922_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jpurol.2021.01.037","volume":"17","author":"LA \u2018t Hoen","year":"2021","unstructured":"\u2018t Hoen LA, Bogaert G, Radmayr C, Dogan HS, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Bhatt NR, Stein R (2021) Update of the EAU\/ESPU guidelines on urinary tract infections in children. J Pediatr Urol 17:200\u2013207. https:\/\/doi.org\/10.1016\/j.jpurol.2021.01.037","journal-title":"J Pediatr Urol"},{"key":"5922_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/J.ACKD.2011.07.006","volume":"18","author":"TK Mattoo","year":"2011","unstructured":"Mattoo TK (2011) Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 18:348. https:\/\/doi.org\/10.1053\/J.ACKD.2011.07.006","journal-title":"Adv Chronic Kidney Dis"},{"key":"5922_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00467-015-3130-6","volume":"30","author":"K Tullus","year":"2015","unstructured":"Tullus K (2015) Outcome of post-infectious renal scarring. Pediatr Nephrol 30:1375\u20131377","journal-title":"Pediatr Nephrol"},{"key":"5922_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapediatrics.2014.637","volume":"168","author":"N Shaikh","year":"2014","unstructured":"Shaikh N, Craig JC, Rovers MM, Da Dalt L, Gardikis S, Hoberman A, Montini G, Rodrigo C, Taskinen S, Tuerlinckx D, Shope T (2014) Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr 168:893\u2013900. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.637","journal-title":"JAMA Pediatr"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamapediatrics.2019.2504","volume":"173","author":"N Shaikh","year":"2019","unstructured":"Shaikh N, Haralam MA, Kurs-Lasky M, Hoberman A (2019) Association of renal scarring with number of febrile urinary tract infections in children. JAMA Pediatr 173:949\u2013952. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.2504","journal-title":"JAMA Pediatr"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/apa.13636","volume":"106","author":"KA Karavanaki","year":"2017","unstructured":"Karavanaki KA, Soldatou A, Koufadaki AM, Tsentidis C, Haliotis FA, Stefanidis CJ (2017) Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring. Acta Paediatr 106:149\u2013154. https:\/\/doi.org\/10.1111\/apa.13636","journal-title":"Acta Paediatr"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1872213X13666181228154940","volume":"13","author":"AKC Leung","year":"2019","unstructured":"Leung AKC, Wong AHC, Leung AAM, Hon KL (2019) Urinary tract infection in children. Recent Pat Inflamm Allergy Drug Discov 13:2\u201318. https:\/\/doi.org\/10.2174\/1872213X13666181228154940","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1542\/peds.2007-2894","volume":"122","author":"IK Hewitt","year":"2008","unstructured":"Hewitt IK, Zucchetta P, Rigon L, Maschio F, Molinari PP, Tomasi L, Toffolo A, Pavanello L, Crivellaro C, Bellato S, Montini G (2008) Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics 122:486\u2013490. https:\/\/doi.org\/10.1542\/peds.2007-2894","journal-title":"Pediatrics"},{"key":"5922_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/archdischild-2020-320591","volume":"106","author":"J Meena","year":"2021","unstructured":"Meena J, Kumar J (2021) Adjuvant corticosteroids for prevention of kidney scarring in children with acute pyelonephritis: a systematic review and meta-analysis. Arch Dis Child 106:1081\u20131086. https:\/\/doi.org\/10.1136\/archdischild-2020-320591","journal-title":"Arch Dis Child"},{"key":"5922_CR11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/S00467-012-2156-2","volume":"27","author":"D Tramma","year":"2012","unstructured":"Tramma D, Hatzistylianou M, Gerasimou G, Lafazanis V (2012) Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring. Pediatr Nephrol 27:1525\u20131530. https:\/\/doi.org\/10.1007\/S00467-012-2156-2","journal-title":"Pediatr Nephrol"},{"key":"5922_CR12","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00467-008-0864-4","volume":"23","author":"M Sharifian","year":"2008","unstructured":"Sharifian M, Anvaripour N, Karimi A, Fahimzad A, Mohkam M, Dalirani R, Gholikhani F, Rafiee MA (2008) The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis. Pediatr Nephrol 23:1511\u20131516. https:\/\/doi.org\/10.1007\/s00467-008-0864-4","journal-title":"Pediatr Nephrol"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00467-021-05117-5","volume":"36","author":"L Da Dalt","year":"2021","unstructured":"Da Dalt L, Bressan S, Scozzola F, Vidal E, Gennari M, La Scola C, Anselmi M, Miorin E, Zucchetta P, Azzolina D, Gregori D, Montini G (2021) Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size. Pediatr Nephrol 36:3681\u20133692. https:\/\/doi.org\/10.1007\/s00467-021-05117-5","journal-title":"Pediatr Nephrol"},{"key":"5922_CR14","doi-asserted-by":"publisher","first-page":"e496","DOI":"10.1542\/peds.2010-0297","volume":"128","author":"Y-Y Huang","year":"2011","unstructured":"Huang Y-Y, Chen M-J, Chiu N-T, Chou H-H, Lin K-Y, Chiou Y-Y (2011) Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring. Pediatrics 128:e496\u2013e504. https:\/\/doi.org\/10.1542\/peds.2010-0297","journal-title":"Pediatrics"},{"key":"5922_CR15","first-page":"244","volume":"13","author":"J Ghaffari","year":"2019","unstructured":"Ghaffari J, Mohammadjafari H, Mohammadi GH, Mahdavi MR (2019) Assessment the effect of dexamethasone on urinary cytokines and renal scar in children with acute pyelonephritis. Iran J Kidney Dis 13:244\u2013250","journal-title":"Iran J Kidney Dis"},{"issue":"264\u2013269","key":"5922_CR16","doi-asserted-by":"publisher","first-page":"W64","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(264\u2013269):W64. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"5922_CR17","first-page":"ED000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 10:ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16","journal-title":"BMC Med Inform Decis Mak"},{"key":"5922_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"5922_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"5922_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-7-5","volume":"7","author":"JO Friedrich","year":"2007","unstructured":"Friedrich JO, Adhikari NKJ, Beyene J (2007) Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 7:5. https:\/\/doi.org\/10.1186\/1471-2288-7-5","journal-title":"BMC Med Res Methodol"},{"key":"5922_CR22","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00467-021-05398-w","volume":"37","author":"N Rius-Gordillo","year":"2022","unstructured":"Rius-Gordillo N, Ferr\u00e9 N, Gonz\u00e1lez JD, Ibars Z, Parada-Ricart E, Fraga MG, Chocron S, Samper M, Vicente C, Fuertes J, Escribano J, DEXCAR Study Group (2022) Dexamethasone to prevent kidney scarring in acute pyelonephritis: a randomized clinical trial. Pediatr Nephrol 37:2109\u20132118. https:\/\/doi.org\/10.1007\/s00467-021-05398-w","journal-title":"Pediatr Nephrol"},{"key":"5922_CR23","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00467-020-04622-3","volume":"35","author":"N Shaikh","year":"2020","unstructured":"Shaikh N, Shope TR, Hoberman A, Muniz GB, Bhatnagar S, Nowalk A, Hickey RW, Michaels MG, Kearney D, Rockette HE, Charron M, Lim R, Majd M, Shalaby-Rana E, Kurs-Lasky M, Cohen DM, Wald ER, Lockhart G, Pohl HG, Martin JM (2020) Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial. Pediatr Nephrol 35:2113\u20132120. https:\/\/doi.org\/10.1007\/s00467-020-04622-3","journal-title":"Pediatr Nephrol"},{"key":"5922_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF00853599","volume":"1","author":"MP Glauser","year":"1987","unstructured":"Glauser MP, Meylan P, Bille J (1987) The inflammatory response and tissue damage. The example of renal scars following acute renal infection. Pediatr Nephrol 1:615\u2013622. https:\/\/doi.org\/10.1007\/BF00853599","journal-title":"Pediatr Nephrol"},{"key":"5922_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00005392-199909010-00067","volume":"162","author":"HG Pohl","year":"1999","unstructured":"Pohl HG, Rushton HG, Park JS, Chandra R, Majd M (1999) Adjunctive oral corticosteroids reduce renal scarring: the piglet model of reflux and acute experimental pyelonephritis. J Urol 162:815\u2013820. https:\/\/doi.org\/10.1097\/00005392-199909010-00067","journal-title":"J Urol"},{"key":"5922_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0022-5347(05)68319-X","volume":"162","author":"A Huang","year":"1999","unstructured":"Huang A, Palmer LS, Hom D, Anderson AE, Kushner L, Franco I (1999) Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats. J Urol 162:1396\u20131398","journal-title":"J Urol"},{"key":"5922_CR27","doi-asserted-by":"publisher","first-page":"134940","DOI":"10.1155\/2014\/134940","volume":"2014","author":"E Bahat\u00d6zdo\u01e7an","year":"2014","unstructured":"Bahat\u00d6zdo\u01e7an E, \u00d6zdemir T, Arslansoyu\u00c7amlar S, Imamo\u011flu M, Cobano\u011flu \u00dc, S\u00f6nmez B, Tosun \u0130, Do\u011fan I (2014) Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis. Biomed Res Int 2014:134940. https:\/\/doi.org\/10.1155\/2014\/134940","journal-title":"Biomed Res Int"},{"key":"5922_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/s0022-5347(17)35187-x","volume":"151","author":"M Haraoka","year":"1994","unstructured":"Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J (1994) Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 151:1078\u20131080. https:\/\/doi.org\/10.1016\/s0022-5347(17)35187-x","journal-title":"J Urol"},{"key":"5922_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00467-018-4187-9","volume":"35","author":"V Murugapoopathy","year":"2020","unstructured":"Murugapoopathy V, McCusker C, Gupta IR (2020) The pathogenesis and management of renal scarring in children with vesicoureteric reflux and pyelonephritis. Pediatr Nephrol 35:349\u2013357. https:\/\/doi.org\/10.1007\/s00467-018-4187-9","journal-title":"Pediatr Nephrol"},{"key":"5922_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/J.1365-2133.1989.TB01396.X","volume":"121","author":"S Coopman","year":"1989","unstructured":"Coopman S, Degreef H, Dooms-Goossens A (1989) Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 121:27\u201334. https:\/\/doi.org\/10.1111\/J.1365-2133.1989.TB01396.X","journal-title":"Br J Dermatol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-05922-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:02:49Z","timestamp":1697630569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-05922-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-05922-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}